Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain

Y Nisimoto, HM Jackson, H Ogawa, T Kawahara… - Biochemistry, 2010 - ACS Publications
NADPH oxidase 4 (Nox4) is constitutively active, while Nox2 requires the cytosolic
regulatory subunits p47 phox and p67 phox and activated Rac with activation by phorbol 12 …

Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2

G Csányi, E Cifuentes-Pagano, I Al Ghouleh… - Free Radical Biology …, 2011 - Elsevier
In recent years, reactive oxygen species (ROS) derived from the vascular isoforms of
NADPH oxidase, Nox1, Nox2, and Nox4, have been implicated in many cardiovascular …

Melan-A–Specific Cytotoxic T Cells Are Associated With Tumor Regression and Autoimmunity Following Treatment With Anti-CTLA-4

O Klein, LM Ebert, T Nicholaou, J Browning… - Clinical Cancer …, 2009 - AACR
Purpose: Ipilimumab is a monoclonal antibody that blocks the immune-inhibitory interaction
between CTL antigen 4 (CTLA-4) and its ligands on T cells. Clinical trials in cancer patients …

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design

LM Ebert, YC Liu, CS Clements, NC Robson… - Cancer research, 2009 - AACR
The tumor antigen NY-ESO-1 is a promising cancer vaccine target. We describe here a
novel HLA-B7–restricted NY-ESO-1 epitope, encompassing amino acids 60-72 …

Nox5 forms a functional oligomer mediated by self-association of its dehydrogenase domain

T Kawahara, HM Jackson, SME Smith, PD Simpson… - Biochemistry, 2011 - ACS Publications
Nox5 belongs to the calcium-regulated subfamily of NADPH oxidases (Nox). Like other
calcium-regulated Noxes, Nox5 has an EF-hand-containing calcium-binding domain at its N …

[HTML][HTML] Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with …

JS Cebon, M Gore, JF Thompson, ID Davis… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background To compare the clinical efficacy of New York Esophageal squamous cell
carcinoma-1 (NY-ESO-1) vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in …

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

T Nicholaou, W Chen, ID Davis, HM Jackson… - Cancer Immunology …, 2011 - Springer
Background NY-ESO-1 protein formulated in ISCOMATRIX™ results in CD4+, CD8+ T cell
and antibody-mediated immunity. We evaluated persistence of immunity, relapse-free …

[HTML][HTML] Nox4 B-loop creates an interface between the transmembrane and dehydrogenase domains

HM Jackson, T Kawahara, Y Nisimoto… - Journal of biological …, 2010 - ASBMB
By targeting redox-sensitive amino acids in signaling proteins, the NADPH oxidase (Nox)
family of enzymes link reactive oxygen species to physiological processes. We previously …

Revisiting holistic interventions in substance abuse treatment

C Adedoyin, N Burns, HM Jackson… - Journal of Human …, 2014 - Taylor & Francis
Holism is regarded as an effective means of alternative treatment, and there has been an
increase in the number of innovative holistic treatment interventions in diverse fields of …

Developmental memory capacity resources of typical children retrieving picture communication symbols using direct selection and visual linear scanning with fixed …

BT Wagner, HM Jackson - 2006 - ASHA
Purpose This study examined the cognitive demands of 2 selection techniques in
augmentative and alternative communication (AAC), direct selection, and visual linear …